Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
GRX
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,500 Added 0.0% |
$15,405
$10.27 p/Share
|
Jan 28
2025 |
|
MPA
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 9,850 Reduced 0.0% |
$116,919
$11.87 p/Share
|
Jan 28
2025 |
|
MIO
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 200 Added 0.0% |
$2,390
$11.95 p/Share
|
Jan 28
2025 |
|
WRLD
|
Luke J. Umstetter
Officer |
SELL
Open market or private sale
|
Direct | 600 Reduced 3.79% |
$90,000
$150.0 p/Share
|
Jan 28
2025 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1 Added 0.0% |
$1,253
$1253.16 p/Share
|
Jan 28
2025 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 888 Added 0.0% |
$2,539
$2.86 p/Share
|
Jan 28
2025 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Direct | 328 Added 0.6% |
$938
$2.86 p/Share
|
Jan 28
2025 |
|
ANIX
|
Arnold M Baskies
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 4.0% |
$14,100
$2.82 p/Share
|
Jan 28
2025 |
|
UNTY
|
Mary E. Gross |
SELL
Open market or private sale
|
Direct | 3,300 Reduced 15.15% |
$158,532
$48.04 p/Share
|
Jan 28
2025 |
|
USEG
|
Ryan Lewis Smith
CEO |
BUY
Open market or private purchase
|
Direct | 500 Added 0.06% |
$1,190
$2.38 p/Share
|
Jan 28
2025 |
|
ISRG
|
Amal M Johnson
Director |
SELL
Open market or private sale
|
Direct | 4,635 Reduced 27.41% |
$2,626,191
$566.6 p/Share
|
Jan 28
2025 |
|
BKR
|
Maria C Borras
Chief Growth & Experience Ofcr |
SELL
Open market or private sale
|
Direct | 67,250 Reduced 38.81% |
$2,924,030
$43.48 p/Share
|
Jan 28
2025 |
|
KURA
|
Thomas James Doyle
SVP, Finance & Accounting |
SELL
Open market or private sale
|
Direct | 4,949 Reduced 5.31% |
$38,948
$7.87 p/Share
|
Jan 28
2025 |
|
ISRG
|
Amy L Ladd
Director |
SELL
Open market or private sale
|
Direct | 150 Reduced 18.27% |
$84,990
$566.6 p/Share
|
Jan 28
2025 |
|
KURA
|
Brian T. Powl
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 1,583 Reduced 2.58% |
$12,458
$7.87 p/Share
|
Jan 28
2025 |
|
KURA
|
Francis Burrows
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 2,166 Reduced 9.47% |
$17,046
$7.87 p/Share
|
Jan 28
2025 |
|
KURA
|
Kathleen Ford
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,817 Reduced 7.84% |
$14,299
$7.87 p/Share
|
Jan 28
2025 |
|
KURA
|
Teresa Brophy Bair
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 7,281 Reduced 6.32% |
$57,301
$7.87 p/Share
|
Jan 28
2025 |
|
KURA
|
Mollie Leoni
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 4,963 Reduced 5.32% |
$39,058
$7.87 p/Share
|
Jan 28
2025 |
|
TDY
|
Melanie Susan Cibik
EVP, GenCounsel, CCO & Sec. |
SELL
Open market or private sale
|
Direct | 4,865 Reduced 15.16% |
$2,481,636
$510.1 p/Share
|
Jan 28
2025 |
|
SKYH
|
Boston Omaha Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 11,475 Reduced 0.11% |
$129,897
$11.32 p/Share
|
Jan 28
2025 |
|
RYAN
|
Nicholas Dominic Cortezi
Director |
SELL
Open market or private sale
|
Indirect | 35,000 Reduced 0.0% |
$2,277,100
$65.06 p/Share
|
Jan 28
2025 |
|
AGBAR
|
Robert E. Diamond Jr. |
SELL
Open market or private sale
|
Indirect | 40,000 Reduced 0.0% |
$74,000
$1.85 p/Share
|
Jan 28
2025 |
|
PDEX
|
Raymond E Cabillot
Director |
SELL
Open market or private sale
|
Indirect | 5,381 Reduced 0.0% |
$224,064
$41.64 p/Share
|
Jan 28
2025 |
|
EWBC
|
Jack C Liu
Director |
SELL
Open market or private sale
|
Direct | 725 Reduced 4.38% |
$75,762
$104.5 p/Share
|
Jan 28
2025 |
|
EXPI
|
Glenn Darrel Sanford
CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 0.06% |
$289,750
$11.59 p/Share
|
Jan 28
2025 |
|
HGTY
|
Robert I Kauffman
Director |
SELL
Open market or private sale
|
Indirect | 2,833 Reduced 0.0% |
$27,735
$9.79 p/Share
|
Jan 28
2025 |
|
OPK
|
Phillip Md Et Al Frost
CEO & Chairman |
BUY
Open market or private purchase
|
Indirect | 47,537 Added 0.0% |
$69,879
$1.47 p/Share
|
Jan 28
2025 |
|
VALF
|
Robert W Elsasser
President |
BUY
Open market or private purchase
|
Direct | 100,000 Added 96.17% |
$2,511,000
$25.11 p/Share
|
Jan 28
2025 |
|
ADBE
|
Jillian Forusz
SVP & CAO |
SELL
Open market or private sale
|
Direct | 334 Reduced 11.06% |
$145,567
$435.83 p/Share
|
Jan 28
2025 |
|
K
|
Kellogg W K Foundation Trust |
SELL
Open market or private sale
|
Direct | 114,583 Reduced 0.24% |
$9,385,493
$81.91 p/Share
|
Jan 28
2025 |
|
PCYG
|
Randall K Fields
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.0% |
$104,750
$20.95 p/Share
|
Jan 28
2025 |
|
MSBI
|
Jeffrey C. Smith |
BUY
Open market or private purchase
|
Direct | 650 Added 1.9% |
$12,324
$18.96 p/Share
|
Jan 28
2025 |
|
MSBI
|
Donald J. Spring
Chief Accounting Officer |
BUY
Open market or private purchase
|
Direct | 800 Added 33.33% |
$19,000
$23.75 p/Share
|
Jan 28
2025 |
|
UCASU
|
Xianghong Wu
Major Member of GP |
BUY
Open market or private purchase
|
Direct | 20,000 Added 41.75% |
$13,600
$0.68 p/Share
|
Jan 28
2025 |
|
UNOV
|
Ernesto L Flores
CFO |
BUY
Open market or private purchase
|
Direct | 43,478 Added 31.4% |
$9,999
$0.23 p/Share
|
Jan 28
2025 |
|
RLEA
|
Hua Wang
CFO and Secretary |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 1.71% |
$100,000
$2.5 p/Share
|
Jan 27
2025 |
|
WULF
|
Michael C. Bucella
Director |
BUY
Open market or private purchase
|
Direct | 4,796 Added 2.28% |
$19,999
$4.17 p/Share
|
Jan 27
2025 |
|
PCSA
|
Justin W Yorke |
BUY
Open market or private purchase
|
Indirect | 12,400 Added 0.0% |
$9,920
$0.8 p/Share
|
Jan 27
2025 |
|
FRD
|
Sandra Kay Scott
Director |
BUY
Open market or private purchase
|
Direct | 700 Added 7.94% |
$9,947
$14.21 p/Share
|
Jan 27
2025 |
|
AKRO
|
Catriona Yale
Chief Development Officer |
SELL
Open market or private sale
|
Direct | 53,590 Reduced 35.91% |
$3,003,183
$56.04 p/Share
|
Jan 27
2025 |
|
AKRO
|
Catriona Yale
Chief Development Officer |
SELL
Open market or private sale
|
Direct | 49,074 Reduced 33.91% |
$2,750,106
$56.04 p/Share
|
Jan 27
2025 |
|
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,442 Reduced 1.32% |
$233,416
$161.87 p/Share
|
Jan 27
2025 |
|
AKRO
|
Andrew Cheng
President and CEO |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 4.02% |
$1,669,800
$55.66 p/Share
|
Jan 27
2025 |
|
AKRO
|
Patrick Lamy
Senior VP, Commercial Strategy |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 12.99% |
$285,150
$57.03 p/Share
|
Jan 27
2025 |
|
AKRO
|
Timothy Rolph
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 31,250 Reduced 15.51% |
$1,743,125
$55.78 p/Share
|
Jan 27
2025 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 22,366 Reduced 0.0% |
$14,416,676
$644.58 p/Share
|
Jan 27
2025 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 13,555 Reduced 0.0% |
$8,777,946
$647.58 p/Share
|
Jan 27
2025 |
|
RXT
|
Mark A. Marino
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 14,458 Reduced 0.75% |
$33,831
$2.34 p/Share
|
Jan 27
2025 |
|
RVLV
|
Mmmk Development, Inc. |
SELL
Open market or private sale
|
Direct | 44,962 Reduced 100.0% |
$1,401,915
$31.18 p/Share
|
Jan 27
2025 |